Attached files
| file | filename |
|---|---|
| 10-Q - Emmaus Life Sciences, Inc. | v222791_10q.htm |
| EX-31.2 - Emmaus Life Sciences, Inc. | v222791_ex31-2.htm |
| EX-31.1 - Emmaus Life Sciences, Inc. | v222791_ex31-1.htm |
EXHIBIT 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, in connection with the filing of the Quarterly Report on Form 10-Q for the quarter ended March 31, 2011 (the “Report”) by CNS Response, Inc. (the “Registrant”), the undersigned hereby certifies that to the best of his knowledge:
|
1.
|
the Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
|
|
2.
|
the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.
|
|
Date: May 16, 2011
|
|
/s/ George Carpenter | |
|
George Carpenter
|
|||
|
Chief Executive Officer (Principal Executive Officer)
|
|
|
|
/s/ Paul Buck | |
|
Paul Buck
|
|||
|
Chief Financial Officer (Principal Financial Officer)
|